Integrated Biopharma Inc financial data

Symbol
INBP on OTC
Location
Hillside, NJ
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384 % +33.8%
Quick Ratio 209 % +14%
Debt-to-equity 25.8 % -31.8%
Return On Equity 3.32 % +47.4%
Return On Assets 2.64 % +61.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.1M shares +3.19%
Common Stock, Shares, Outstanding 31.1M shares +3.07%
Entity Public Float 3.11M USD -7.6%
Common Stock, Value, Issued 62K USD +3.33%
Weighted Average Number of Shares Outstanding, Basic 31.1M shares +3.19%
Weighted Average Number of Shares Outstanding, Diluted 31.4M shares +2.52%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) 1.69M USD +113%
Nonoperating Income (Expense) 39K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.75M USD +114%
Income Tax Expense (Benefit) 1.08M USD +179%
Net Income (Loss) Attributable to Parent 672K USD +56.3%
Earnings Per Share, Basic 0 USD/shares +100%
Earnings Per Share, Diluted 0 USD/shares +100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.73M USD +108%
Accounts Receivable, after Allowance for Credit Loss, Current 3.98M USD -9.17%
Inventory, Net 10.5M USD -6.73%
Other Assets, Current 440K USD +1.85%
Assets, Current 19.6M USD +7.17%
Deferred Income Tax Assets, Net 3.27M USD -25.8%
Property, Plant and Equipment, Net 1.82M USD -1.84%
Operating Lease, Right-of-Use Asset 612K USD -60.7%
Assets 25.5M USD -2.46%
Accounts Payable, Current 2.8M USD +1.34%
Liabilities, Current 4.76M USD -21%
Operating Lease, Liability, Noncurrent 183K USD -69.7%
Liabilities 5.05M USD -23.9%
Retained Earnings (Accumulated Deficit) -31.3M USD +2.1%
Stockholders' Equity Attributable to Parent 20.5M USD +4.8%
Liabilities and Equity 25.5M USD -2.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.3M USD +98%
Net Cash Provided by (Used in) Financing Activities -11K USD -57.1%
Net Cash Provided by (Used in) Investing Activities -173K USD -209%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 31.1M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.12M USD +88%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2K USD -83.3%
Deferred Tax Assets, Valuation Allowance 1.78M USD +39.7%
Operating Lease, Liability 1.32M USD
Depreciation 310K USD -1.59%
Payments to Acquire Property, Plant, and Equipment 173K USD +209%
Lessee, Operating Lease, Liability, to be Paid 1.4M USD
Property, Plant and Equipment, Gross 10.1M USD +2.18%
Operating Lease, Liability, Current 429K USD -55%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 661K USD
Deferred Income Tax Expense (Benefit) 68K USD -65.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 77K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 64K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.37M USD -13.2%
Deferred Federal Income Tax Expense (Benefit) 1.25M USD +305%
Operating Lease, Payments 254K USD -4.51%
Additional Paid in Capital 51.8M USD +0.51%
Depreciation, Depletion and Amortization 77K USD -9.41%
Deferred State and Local Income Tax Expense (Benefit) -183K USD -473%
Interest Expense 52K USD 0%